Adding evolocumab to both moderate- and high-intensity statin therapy lowered low-density lipoprotein cholesterol even further in an international phase III clinical trial reported online May 13 in...

Field of Interest: Cardiology

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.